CODX vs KIM · rev $3.9M vs P/E 27, $16.03B cap
Co-Diagnostics, Inc. Common Stock (CODX) versus Kimco Realty Corporation (KIM) — a side-by-side from cached financials, not a winner call.
Co-Diagnostics, Inc. Common Stock (CODX) is a medical devices company listed on US.
Kimco Realty Corporation (KIM) is a reit - retail company listed on US.
Latest reported CODX revenue for 2024-12-31 was $3.9M. Net income was -$37.6M. Revenue was down 42.5% from 2023-12-31 to 2024-12-31. CODX currently screens at market cap $31.4M.
KIM does not have a complete income-statement cache yet.
CODX currently screens at market cap $31.4M. KIM currently screens at market cap $16.03B and trailing P/E 27.3.
Not investment advice. Open the CODX and KIM stock pages for the full models.
Not investment advice.